Lumify
Active Ingredient(s): Brimonidine TartrateFDA Approved: * December 22, 2017
Pharm Company: * BAUSCH AND LOMB INC
Category: Vision / Eye Health
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Lumify Overview
Brimonidine is a medication used to treat open-angle glaucoma, ocular hypertension, and rosacea.[1][2] In rosacea it improves the redness.[2] It is used as eye drops or applied to the skin.[1][2] Common side effects when used in the eyes include itchiness, redness, and a dry mouth.[1] Common side effects when used on the skin include redness, burning, and headaches.[2] More signific...
Read more Lumify DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine
Recent Lumify Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Brimonidine Tartrate
- Drops: 0.2%
- Gel: 0.33%
- Solution: 0.15%, 0.2%
- Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Other drugs which contain Brimonidine Tartrate or a similar ingredient: (8 results)
- ALPHAGAN Brimonidine1 discussion
- ALPHAGAN P Brimonidine
- BRIMONIDINE
- MIRVASO Brimonidine
- BRIMONIDINE TARTRATE + TIMOLOL MALEATE
- BRINZOLAMIDE + BRIMONIDINE TARTRATE
- COMBIGAN Brimonidine Tartrate + Timolol Maleate2 discussions
- SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions